It was shown that up-regulation of REDD1 induced by hypoxia, energetic and oxidative stress, Gcs, or specific pharmacological activators decreased mTORC1 activity and inhibited the proliferation of cancer cells [8,18,46]. The gene discussed is DDIT4; the disease is cancer.